Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 2, 2004, Pages 427-436

  Jin, Jing ^a   Liao, Zhongxing ^b   Zhang, Zhen ^c   Ajani, Jaffer ^b   Swisher, Stephen ^b   Chang, Joe Y ^b   Jeter, Melanda ^b   Guerrero, Thomas ^b   Stevens, Craig W ^b   Vaporciyan, Ara ^b   Putnam Jr , Joe ^b   Walsh, Garret ^b   Smythe, Roy ^b   Roth, Jack ^b   Yao, James ^b   Allen, Pamela ^b   Cox, James D ^b   Komaki, Ritsuko ^b  

^a CANCER HOSPITAL   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Chemoradiation; Esophageal cancer; Induction chemotherapy

Indexed keywords

CHEMOTHERAPY; DRUG PRODUCTS; PATIENT TREATMENT; RADIOTHERAPY; STATISTICAL METHODS;

CHEMORADIOTHERAPHY; ESOPHAGUS;

ONCOLOGY;

CISPLATIN; FLUOROURACIL; IRINOTECAN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 4544289946     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.03.033     Document Type: Article

References (30)

1. Devesa S., Blot W., Fraumeni J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 83:1998;2049-2053
2. Siewert J., Fink U., Beckurts K., et al. Surgery of squamous cell carcinoma of the esophagus. Ann Oncol. 5:1994;1-7
3. Orringer M., Marshall B., Stirling M. Transhiatal esophagectomy for benign and malignant disease. J Thorac Cardiovasc Surg. 105:1993;265-277
4. Kelsen D., Ginsberg R., Pajak T., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 339:1998;1979-1984
5. Radiation Therapy Oncology Group, Cooper J., Guo M., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer Long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA. 281:1999;1623-1627
6. Bosset J., Gignoux M., Triboulet J., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 337:1997;161-167
7. Walsh T., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 335:1996;462-467
8. Urba S., Orringer M., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 19:2001;305-313
9. Liao Z, Jin J, Zhang Z, et al. Surgical resections may increase survival in patients with stage II and III esophageal cancer treated with concurrent chemoradiation [Abstract]. Puerto Rico. Cancer J 2002;8:486
10. Ajani J., Komaki R., Putnam J., et al. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer. 92:2001;279-286
11. American Joint Committee on Cancer. Manual for staging of cancer. 4th ed:1992;JB Lippincott, Philadelphia
12. Spitz F., Abbruzzese J., Lee J., et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol. 15:1997;928-937
13. Pisters P., Abbruzzese J., Janjan N., et al. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol. 16:1998;3843-3850
14. Evans D., Abbruzzese J., Cleary K., et al. Rapid-fractionation pre-operative chemoradiation for malignant periampullary neoplasms. J R Coll Surg Edinburgh. 40:1995;319-323
15. Ajani J., Ryan B., Rich T., et al. Prolonged chemotherapy for localised squamous carcinoma of the oesophagus. Eur J Cancer. 28A:1992;880-884
16. Stata statistical software. Release 7.0. College Station, TX: Stata Corporation; 2001
17. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481
18. Cox D. Regression models and life tables. J R Stat Soc [Ser B]. 34:1972;187-229
19. Forastiere A., Orringer M., Perez-Tamayo C., et al. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol. 8:1990;119-127
20. Geh J., Crellin A., Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in esophageal cancer. Br J Surg. 88:2001;338-356
21. Hennequin C., Gayet B., Sauvanet A., et al. Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus. Int J Radiat Oncol Biol Phys. 49:2001;657-664
22. Hoffman P.C., Haraf D.J., Ferguson M.K., et al. Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus A long-term analysis. Ann Oncol. 9:1998;647-651
23. Luketich J., Nguyen N., Ramanathan R., et al. Induction and post-operative chemotherapy with paclitaxel, 5-fluorourcial and cisplatin regimen for carcinoma of the esophagus. [Abstract] Prog Proc Am Soc Oncol. 17:1998;295a
24. Lynch T., Choi N., Wright M., et al. A phase I/II trial of preoperative Taxol (T), 5-FU (F) and concurrent boost radiation (XRT) in esophageal cancer. [Abstract] Prog Proc Am Soc Oncol. 16:1997;261a
25. Meluch A.A., Hainsworth J.D., Gray J.R., et al. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer Preliminary results of a Minnie Pearl Cancer Research Network phase II trial. Cancer J Sci Am. 5:1999;84-91
26. Weiner L., Colarusso P., Goldberg M., et al. Combined modality therapy for esophageal cancer Phase I trail of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy. Semin Oncol. 24:(Suppl. 19):1997;S93-S95
27. Stahl M., Wilke H., Fink U., et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer Interim analysis of a phase III trial. J Clin Oncol. 14:1996;829-837
28. Ganem G., Dubray B., Raoul Y., et al. Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagus. J Clin Oncol. 15:1997;701-711
29. Forastiere A., Heitmiller R., Lee D., et al. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am. 3:1997;144-152
30. Heath E, Burtness B, Heitmiller R, et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol. 18:2000;868-876